Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.

MLA

Rice, J.Bradford, et al. “Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.” Neurology and Therapy, vol. 10, no. 1, June 2021, pp. 149–67. EBSCOhost, https://doi.org/10.1007/s40120-020-00219-y.

APA

Rice, J. B., Panaccio, M. P., White, A., Simes, M., Billmyer, E., Downes, N., Niewoehner, J., & Wan, G. J. (2021). Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis. Neurology and Therapy, 10(1), 149–167. https://doi.org/10.1007/s40120-020-00219-y

Chicago

Rice, J Bradford, Mary P Panaccio, Alan White, Mark Simes, Emma Billmyer, Nathaniel Downes, John Niewoehner, and George J Wan. 2021. “Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis.” Neurology and Therapy 10 (1): 149–67. doi:10.1007/s40120-020-00219-y.